S&P 500   3,147.77 (+0.97%)
DOW   28,010.24 (+1.20%)
QQQ   204.98 (+1.26%)
AAPL   270.29 (+1.77%)
MSFT   151.46 (+1.02%)
GOOGL   1,340.21 (+1.61%)
AMZN   1,749.62 (-0.63%)
CGC   18.59 (-0.05%)
NVDA   212.45 (+1.45%)
BABA   201.90 (+0.95%)
GE   10.98 (+1.76%)
TSLA   335.96 (+0.88%)
T   38.22 (+0.08%)
AMD   39.85 (+0.40%)
F   9.00 (+0.67%)
NFLX   307.25 (+0.96%)
BAC   33.70 (+1.84%)
GILD   67.29 (+0.81%)
DIS   147.91 (+0.32%)
S&P 500   3,147.77 (+0.97%)
DOW   28,010.24 (+1.20%)
QQQ   204.98 (+1.26%)
AAPL   270.29 (+1.77%)
MSFT   151.46 (+1.02%)
GOOGL   1,340.21 (+1.61%)
AMZN   1,749.62 (-0.63%)
CGC   18.59 (-0.05%)
NVDA   212.45 (+1.45%)
BABA   201.90 (+0.95%)
GE   10.98 (+1.76%)
TSLA   335.96 (+0.88%)
T   38.22 (+0.08%)
AMD   39.85 (+0.40%)
F   9.00 (+0.67%)
NFLX   307.25 (+0.96%)
BAC   33.70 (+1.84%)
GILD   67.29 (+0.81%)
DIS   147.91 (+0.32%)
S&P 500   3,147.77 (+0.97%)
DOW   28,010.24 (+1.20%)
QQQ   204.98 (+1.26%)
AAPL   270.29 (+1.77%)
MSFT   151.46 (+1.02%)
GOOGL   1,340.21 (+1.61%)
AMZN   1,749.62 (-0.63%)
CGC   18.59 (-0.05%)
NVDA   212.45 (+1.45%)
BABA   201.90 (+0.95%)
GE   10.98 (+1.76%)
TSLA   335.96 (+0.88%)
T   38.22 (+0.08%)
AMD   39.85 (+0.40%)
F   9.00 (+0.67%)
NFLX   307.25 (+0.96%)
BAC   33.70 (+1.84%)
GILD   67.29 (+0.81%)
DIS   147.91 (+0.32%)
S&P 500   3,147.77 (+0.97%)
DOW   28,010.24 (+1.20%)
QQQ   204.98 (+1.26%)
AAPL   270.29 (+1.77%)
MSFT   151.46 (+1.02%)
GOOGL   1,340.21 (+1.61%)
AMZN   1,749.62 (-0.63%)
CGC   18.59 (-0.05%)
NVDA   212.45 (+1.45%)
BABA   201.90 (+0.95%)
GE   10.98 (+1.76%)
TSLA   335.96 (+0.88%)
T   38.22 (+0.08%)
AMD   39.85 (+0.40%)
F   9.00 (+0.67%)
NFLX   307.25 (+0.96%)
BAC   33.70 (+1.84%)
GILD   67.29 (+0.81%)
DIS   147.91 (+0.32%)
Log in

OTCMKTS:INBP - Integrated BioPharma Stock Price, Forecast & News

$0.25
+0.01 (+4.17 %)
(As of 12/6/2019 02:24 PM ET)
Today's Range
$0.25
Now: $0.25
$0.25
50-Day Range
$0.20
MA: $0.24
$0.26
52-Week Range
$0.10
Now: $0.25
$0.31
VolumeN/A
Average Volume12,760 shs
Market Capitalization$7.39 million
P/E Ratio4.33
Dividend YieldN/A
Beta-0.46
Integrated Biopharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through three segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Naturally Noni, Peaceful Sleep, Green Envy, FiberCal, and Wheatgrass brands, as well as other branded proprietary nutraceutical products. The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet; and distributes fine natural botanicals, including multi minerals, as well as raw materials. This segment also provides warehousing and fulfilment services. The company was formerly known as Integrated Health Technologies, Inc. Integrated Biopharma, Inc. was founded in 1979 and is based in Hillside, New Jersey.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:INBP
CUSIPN/A
Phone888-319-6962

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$49.98 million
Cash Flow$0.08 per share
Book Value$0.06 per share

Profitability

Net Income$1.69 million

Miscellaneous

Employees128
Market Cap$7.39 million
Next Earnings Date2/12/2020 (Estimated)
OptionableNot Optionable

Receive INBP News and Ratings via Email

Sign-up to receive the latest news and ratings for INBP and its competitors with MarketBeat's FREE daily newsletter.


Integrated BioPharma (OTCMKTS:INBP) Frequently Asked Questions

What is Integrated BioPharma's stock symbol?

Integrated BioPharma trades on the OTCMKTS under the ticker symbol "INBP."

When is Integrated BioPharma's next earnings date?

Integrated BioPharma is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Integrated BioPharma.

Has Integrated BioPharma been receiving favorable news coverage?

Media headlines about INBP stock have trended neutral on Friday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Integrated BioPharma earned a daily sentiment score of 0.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Integrated BioPharma.

Who are some of Integrated BioPharma's key competitors?

What other stocks do shareholders of Integrated BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integrated BioPharma investors own include Tilray (TLRY), Cancer Genetics (CGIX), Ares Capital (ARCC) and AGNC Investment (AGNC).

Who are Integrated BioPharma's key executives?

Integrated BioPharma's management team includes the folowing people:
  • Mr. E. Gerald Kay, Exec. Chairman (Age 83)
  • Ms. Riva Kay Sheppard, Co-CEO & Director (Age 52)
  • Ms. Christina Kay, Co-CEO & Director (Age 49)
  • Ms. Dina L. Masi, Sr. VP, CFO & Sec. (Age 58)
  • Mr. Jamie E. Levey, Head of Investor Relations

How do I buy shares of Integrated BioPharma?

Shares of INBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Integrated BioPharma's stock price today?

One share of INBP stock can currently be purchased for approximately $0.25.

How big of a company is Integrated BioPharma?

Integrated BioPharma has a market capitalization of $7.39 million and generates $49.98 million in revenue each year. Integrated BioPharma employs 128 workers across the globe.View Additional Information About Integrated BioPharma.

What is Integrated BioPharma's official website?

The official website for Integrated BioPharma is http://www.integratedbiopharma.com/.

How can I contact Integrated BioPharma?

Integrated BioPharma's mailing address is 225 LONG AVENUE BUILDING 15, HILLSIDE NJ, 07205. The company can be reached via phone at 888-319-6962.


MarketBeat Community Rating for Integrated BioPharma (OTCMKTS INBP)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Integrated BioPharma and other stocks. Vote "Outperform" if you believe INBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INBP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel